Kyocera presents its innovation strategy for medical ceramics at DKOU 2025

New production site in Waiblingen as European milestone

Through its new production facility in Waiblingen near Stuttgart, Germany, which was officially opened on the 1st of October 2025, Kyocera is consistently expanding its European presence in the medical technology market. On an area of around 10,800 m² – including 5,400 m² of production space and 1,400 m² of office space – the company has created a state-of-the-art center for the manufacture of high-performance medical ceramics. Featuring a fully automated and intelligently designed production environment, the site offers optimized material flows, autonomous mobile robots and advanced intralogistics solutions. Furthermore, the building is designed to meet or even exceed current regulations regarding carbon neutral production, ESG standardization, and DGNB and/or LEED certification.

BIOCERAM AZUL^® – Cutting-edge solution for endoprosthetics

After decades of successfully marketing its medical technology products in Japan, Kyocera is now pursuing its expansion strategy in Europe with the aim of strategically developing its innovations and sustainable solutions in the European medical sector. The new plant in Waiblingen focuses on the production of BIOCERAM AZUL^® high-performance ceramics, which are used to manufacture ceramic ball heads used in hip implants and other orthopedic applications. Thanks to their high fracture toughness and outstanding biocompatibility, they offer a cutting-edge solution in the field of hip endoprosthetics. Delivery is scheduled to begin in the first quarter of 2026.

Reliable partner for medical ceramics

“Initially, our goal is to establish ourselves as a reliable supplier for ceramic hip joint components and then, in the medium term, to act as a strategic partner for medical ceramic solutions both within and outside the field of orthopaedics,” explains Dr Fabian Preuß, Managing Director of KYOCERA Fineceramics Medical GmbH. In order to achieve this objective, Kyocera will continue optimising its medical ceramics to make a significant contribution to the medical sector and take a leading position in the European market for medical ceramics.

About DKOU 2025

German Congress for Orthopaedics and Trauma Surgery (DKOU, Deutscher Kongress für Orthopädie und Unfallchirurgie) is Europe's biggest specialist congress in this sector offering a central platform for sharing the latest technological, scientific and clinical developments. Covering a total of 5,000 m² of exhibition space, this year's congress will take place at the CityCube in Berlin and is expected to attract 200 companies and more than 8,000 delegates from 50 countries.

Overview: Kyocera at DKOU 2025